Charles Z. Ding

Ltd. 288 Fute Zhong Road
Waigaoqiao, 200131, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Preparation and pharmacokinetic study of mebendazole complex with HP-beta-cyclodextrin.

Preparation and pharmacokinetic study of mebendazole complex with HP-beta-cyclodextrin.

Journal: Frontiers in veterinary science

Published: April 13, 2025

Discovery and preclinical profile of YK-2168, a differentiated selective CDK9 inhibitor in clinical development.

Discovery and preclinical profile of YK-2168, a differentiated selective CDK9 inhibitor in clinical development.

Journal: Bioorganic & medicinal chemistry letters

Published: July 09, 2024

Randomly Methylated β-Cyclodextrin Inclusion Complex with Ketoconazole: Preparation, Characterization, and Improvement of Pharmacological Profiles.

Randomly Methylated β-Cyclodextrin Inclusion Complex with Ketoconazole: Preparation, Characterization, and Improvement of Pharmacological Profiles.

Journal: Molecules (Basel, Switzerland)

Published: March 09, 2024

Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor.

Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor.

Journal: Bioorganic & medicinal chemistry letters

Published: March 08, 2024

Preparation and evaluation of fenbendazole methyl-β-cyclodextrin inclusion complexes.

Preparation and evaluation of fenbendazole methyl-β-cyclodextrin inclusion complexes.

Journal: BMC veterinary research

Published: November 22, 2023

The Use of Cyclodextrin Inclusion Complexes to Increase the Solubility and Pharmacokinetic Profile of Albendazole.

The Use of Cyclodextrin Inclusion Complexes to Increase the Solubility and Pharmacokinetic Profile of Albendazole.

Journal: Molecules (Basel, Switzerland)

Published: September 30, 2023

Solubility and Pharmacokinetic Profile Improvement of Griseofulvin through Supercritical Carbon Dioxide-Assisted Complexation with HP-γ-Cyclodextrin.

Solubility and Pharmacokinetic Profile Improvement of Griseofulvin through Supercritical Carbon Dioxide-Assisted Complexation with HP-γ-Cyclodextrin.

Journal: Molecules (Basel, Switzerland)

Published: September 12, 2023

Improvement of solubility and pharmacokinetic profile of hepatoprotector icariin through complexation with HP-γ-cyclodextrin.

Improvement of solubility and pharmacokinetic profile of hepatoprotector icariin through complexation with HP-γ-cyclodextrin.

Journal: Frontiers in pharmacology

Published: January 31, 2023

Tilmicosin/γ-Cyclodextrin complexation through supercritical carbon dioxide assistance and its pharmacokinetic and antibacterial study.

Tilmicosin/γ-Cyclodextrin complexation through supercritical carbon dioxide assistance and its pharmacokinetic and antibacterial study.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: September 14, 2022

Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infection.

Discovery and preclinical evaluations of GST-HG131, a novel HBV antigen inhibitor for the treatment of chronic hepatitis B infection.

Journal: Bioorganic & medicinal chemistry letters

Published: July 13, 2022

Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent.

Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent.

Journal: Bioorganic & medicinal chemistry letters

Published: May 24, 2022

Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent.

Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent.

Journal: Bioorganic & medicinal chemistry letters

Published: April 24, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026